ANAkemi Nishide

Akemi Nishide

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Akemi Nishide has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A scoping review of observation studies of overweight/obese children with intellectual disabilities in East Asian countries: China, Korea, Taiwan, Hong Kong and Japan

    by Akemi Nishide, Natsuki Shioda

    Introduction There have been several current review studies on factors influencing obesity in children worldwide, but not children with intellect | POSTER

  • Sampling methods for a cross-sectional study on the anthropometric characteristics and nutrition intake of children with intellectual disabilities in Japan

    by Akemi Nishide

    Introduction Few studies have investigated the anthropometric characteristics and nutrition intake of Japanese children with intellectual disabil |

  • Open Access

    A Risk Comparison between Lifestyle, Socioeconomic Status, and Radiation: A Cohort Study of Cancer Mortality among Japanese Nuclear Workers (J-EPISODE)

    by Shin’iChi Kudo, Akemi Nishide, Hiroshige Furuta, Noboru Ishizawa, Shin Saigusa

    The health effects of low-dose radiation exposure have been a source of controversy. One possible reason is that epidemiological studies that compare radiation risk with other factors, such as lifestyle or socioeconomic status, have been limited. The aim of this study is to conduct a comparison of the cancer risk of mortality between radiation, lifestyle habits (such as smoking), and socioeconomic status (such as years of education) among Japanese nuclear workers. We assembled a cohort of 41,742 male nuclear workers in Japan who answered a lifestyle questionnaire survey conducted during 2003–2004. To exclude systematic errors caused by missing values, we used multiple imputation and Poisson regression to estimate relative risks and confidence intervals for lifestyle habits, socioeconomic status, and radiation. The total person-y from 2005 to 2010 were 215,000. The mean age and cumulative dose were 54.9 y and 24.8 mSv (10-y lagged dose), respectively. Significantly high relative risks were determined for smoking, alcohol consumption, frequency of medical examination, breakfast intake, sleep, and body mass index. Further, significantly high relative risks of radiation were shown for lung cancer and smoking-related cancers. Since the simultaneous inclusion of radiation and non-radiation variables in the model for relative risk (RR) calculation means that the calculated radiation RR is the result of adjustment by other variables, the risk of cancer from low-dose radiation, if any, is less than smoking and probably less than other lifestyle factors.


  • Open Access

    Organ Dose Reconstruction Applicable for a Japanese Nuclear Worker Cohort: J-EPISODE

    by Hiroshige Furuta, Kaoru Sato, Akemi Nishide, Shin’iChi Kudo, Shin Saigusa

    An evaluation of cancer risk based on organ-absorbed dose is underway for the Japanese Epidemiological Study on Low-Dose Radiation Effects (J-EPISODE), which has analyzed health effects in association with radiation exposure evaluated with the personal dose equivalent H p(10). Although the concept of effective dose and its operational definition of H p(10) are widely used for radiological protection purposes, effective dose is not recommended for epidemiological evaluation. Organ-absorbed dose was instead adopted for the IARC 15-Country Collaborative study (15-Country study), the International Nuclear Workers Study (INWORKS), the Mayak worker study, and the Life Span Study (LSS) of atomic bomb survivors. The reconstruction method in J-EPISODE followed in principle the approach adopted in the 15-Country Study. As part of the approach of J-EPISODE, a conversion factor from photon dosimeter reading to air kerma was developed using dosimeter response data, which were measured by the experiment using an anthropomorphic phantom, and it was confirmed that the 15-Country study’s assumption of photon energy and geometry distribution in a work environment applied to Japanese nuclear workers. This article focuses on a method for reconstructing the conversion factor from photon dosimeter reading to organ-absorbed photon dose for a Japanese nuclear worker cohort. The model for estimating the conversion factor was defined under the assumption of a lognormal distribution from three concerned bias factors: (1) a dosimeter reading per air kerma, i.e., dosimeter response; (2) an organ-absorbed dose per air kerma; and (3) a factor relating to the differences in dose concepts and calibration practices between the roentgen dosimeter era and the present. Dosimeter response data were cited from the companion paper. Data on organ-absorbed photon dose per air kerma were estimated using a voxel phantom with the average Japanese adult male height and weight. The bias factor for the recorded dose in the roentgen era was defined, considering the backscatter radiation from the human body. The estimated values of organ-absorbed photon dose per air kerma were almost the same as those in ICRP Publication 116, revealing that the effect of differences in body size was almost negligible. The conversion factors from dosimeter reading to organ-absorbed dose were estimated by period (the roentgen era or from then), nuclear facility type (nuclear power plant or other), dosimeter type, and tissue or organ. The estimated conversion factors ranged from 0.7 to 0.9 (Gy Sv−1). The estimated cumulative organ-absorbed photon dose for the participants of J-EPISODE demonstrated that organ-absorbed dose values were approximately 0.8 times the recorded doses if neglecting dose-unit differences. J-EPISODE reconstructed an organ-absorbed dose conversion factor and will evaluate the risk of cancer mortality and morbidity using the organ-absorbed dose in the future.